AVE 0.00% 0.2¢ avecho biotechnology limited

current sp, page-107

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    and as H said we are grossly undervalued compared with what we have got....

    Doesn't really matter what H says on this, the market decides what they value the company at, and it's up to H and co to make investors change their mind. I'm sure if it was perceived so grossly undervalued, I'm sure some of POHs directors and key management personnel (excluding H) who hold virtually no shares, would have ears pinned back buying them up. But they're not.

    Share price will be driven by achieving goals and I believe eyes are firmly placed on the Oxy patch developments.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.